study question: Does insulin-like growth factor 1 (IGF1) increase adhesion competency of blastocysts to increase attachment to uterine epithelial cells in vitro?
Introduction
Unsuccessful embryo implantation is the major cause of human assisted reproductive technology (ART) failure (Miller et al., 2012) . Implantation is a highly coordinated event in which the receptive endometrium is primed to receive adhesion-competent blastocysts. Growth factors produced by both the embryo and the female reproductive tract are thought to support development of the blastocyst to an adhesion-competent state, which is synchronized with uterine receptivity, to ensure blastocyst implantation ability (Wang et al., 2000; Armant, 2005) . Therefore, an understanding of how growth factors influence implantation is essential to improve ART.
Insulin-like growth factor 1 (IGF1) is one particular growth factor that is present at the maternal-embryo interface in a number of mammalian species (Murphy et al., 1987; Kapur et al., 1992; Lighten et al., 1998; Slater and Murphy, 1999) . At the time of implantation in the rat IGF1 is strongly expressed in the basal lamina and the apical surface of uterine epithelial cells, which are the sites of trophoblast invasion and attachment, respectively (Slater and Murphy, 1999) . Additionally IGF1 is secreted by mouse embryos (Inzunza et al., 2010) . The IGF1 receptor (IGF1R) is expressed throughout mouse preimplantation stages of development (Inzunza et al., 2010) and is expressed apically on trophoblast cells (Bedzhov et al., 2012) , which are the cells that make first contact with the uterine epithelium. High levels of IGF1, which cause IGF1R down-regulation, decrease normal blastocyst implantation sites and increase resorption sites (Pinto et al., 2002) . Additionally, beads soaked in IGF1 elicit a decidual response in the uterus that mimics that of a blastocyst (Paria et al., 2001) . Despite this knowledge of IGF1/IGF1R expression in the embryo and uterine tissue, it is not known whether IGF1 affects blastocyst adhesion competency or the mechanisms by which IGF1 influences early implantation.
Acquisition of adhesion competence by the blastocyst involves an accumulation of integrins on the apical surface of trophoblast cells. Implantation depends, in part, on the bridging between integrins on the endometrium and the blastocyst by extracellular matrix (ECM) proteins such as fibronectin (Kaneko et al., 2013) . Integrin a5b1 subunits increase on the apical surface of adhesion competent mouse blastocysts, and this correlates with an increased ability to bind fibronectin Schultz et al., 1997; Wang et al., 2002) . Most ECM proteins bind to multiple integrins, for example fibronectin, which binds the a5b1, avb3 and aIIb3 integrins in mouse blastocysts (Sutherland et al., 1993; Schultz and Armant 1995; Yelian et al., 1995; Schultz et al., 1997) .
The process of integrin activation, which occurs via inside-out signalling, regulates integrin affinity for ECM proteins. This inside-out signalling is mediated by a number of signalling pathways, such as the PI3 kinase (PI3K)/Akt pathway (Somanath et al., 2007) . Akt is activated by IGF1 in mouse blastocysts (Green and Day, 2013) and treatment of trophoblast cells with IGF1 increases fibronectin binding mediated by a5b1 and avb3 (Kabir-Salmani et al., 2002, 2003, 2004) .
The current study investigated the role of IGF1 in attachment, using a well-characterized in vitro model of attachment that involves culture of blastocysts on Ishikawa cells. Ishikawa cells are a well differentiated endometrial adenocarcinoma cell line (Nishida et al., 1985; Hannan et al., 2010) that displays apical adhesiveness (Heneweer et al., 2005) and a similar integrin expression profile to a receptive endometrium, under the control of estrogen and progesterone (Lessey et al., 1996; Castelbaum et al., 1997) . Embryos of different species including mouse, rat and human (Singh et al., 2010; Kaneko et al., 2011a Kaneko et al., , 2012 Kaneko et al., , 2013 Kang et al., 2014) are known to attach to Ishikawa cells. These characteristics make Ishikawa cells an invaluable model for the study of implantation in vitro, especially as the use of human embryos is limited by availability (Kang et al., 2014) . In the present study we demonstrate that IGF1 increased apical fibronectin expression on blastocysts and attachment of blastocysts to Ishikawa cells, as well as blastocyst invasiveness. These actions of IGF1 were all prevented by inhibition of the PI3K/Akt pathway. These data suggest an important role for IGF1 in the acquisition of blastocyst adhesion competence due to regulation of fibronectin expression. Furthermore, our results indicate that addition of IGF1 to the culture system may improve the success of human assisted reproduction by improving the adhesion competence of blastocysts.
Materials and Methods
Use of animals and ethical approval, ovulation induction and embryo collection and culture
Procedures involving the use of animals were conducted in accordance with the Australian Code of Practice for Use of Animals in Research and were approved by the University of Sydney Animal Care and Ethics Committee. The Quackenbush Swiss (QS) strain of mice was used (Animal Resource Centre, Perth, Australia). Mice were housed under a 12-h light: 12-h dark cycle (light; 06:00-18:00), and housed in a conventional holding facility where the temperature was maintained at 20 -228C and the humidity kept at 55%. Mice had free access to water and commercially prepared pellets. Female mice were caged in groups of 10 whilst male mice were caged singly. Ovulation induction of female mice (4-10 weeks old) was achieved by intraperitoneal injection of 10 I.U. of pregnant mare serum gonadotrophin (PMSG; Intervet, Sydney, Australia) followed 48 h later by intraperitoneal injection of 10 I.U. of hCG (Intervet) as previously described (Nasr-Esfahani et al., 1990 ). Superovulated female mice were then paired with a stud male QS mouse (10-30 weeks old) overnight. The presence of a vaginal plug the following day indicated successful mating and this was considered to be Day 1 of pregnancy.
Female mice were sacrificed on Day 4 of pregnancy, 90 -94 h after hCG administration, in order to recover early blastocysts. The oviducts and uterine horns were flushed with Hepes-buffered modified synthetic human tubal fluid medium (Hepes mod-HTF; 300 mosM/l, pH 7.4) containing 0.3 mg/ml bovine serum albumin (BSA; Sigma-Aldrich; St Louis, MO, USA). Blastocysts were then collected and cultured for 24 -28 h, to enable hatching from the zona pellucida (Day 5 Blastocysts), in Potassium simplex IGF1 Increases mouse blastocyst attachment in vitro optimized medium (KSOM; 260 mosM/l, pH 7.4) containing 0.3 mg/ml BSA. All media was made up from stock solutions prepared from tissue culture grade reagents (Sigma-Aldrich) as previously described (Green and Day, 2013) . All blastocysts used in this study were collected on Day 4 and allowed to hatch overnight before treatment (all blastocysts used were hatched or near completion of hatching).
Recombinant mouse IGF1 (R&D Systems; Minneapolis, MN USA) was reconstituted at 100 mg/ml in sterile phosphate-buffered saline (PBS; AMRESCO; Solon, OH, USA). Mature mouse IGF1 shares 94% amino acid sequence homology with human IGF1 and exhibits species cross reactivity (Bell et al., 1986) . Specifically, R&D Systems test their mouse IGF1 activity on human MCF-7 breast cancer cell proliferation. Thus mouse IGF1 was used in all of the experiments. IGF1 at 10 ng/ml has been used to see positive effects on embryo development (Green and Day, 2013) . Higher concentrations, such as 30, 100 and 1000 ng/ml IGF1, are known to have detrimental effects on blastocysts and cause IGF1R down-regulation (Chi et al., 2000; Green and Day, 2013) , and this range of IGF1 concentrations has been used in this study to investigate the mechanisms of IGF1 in attachment of the embryo to uterine epithelial cells.
To determine a direct effect of IGF1 through the IGF1R, an IGF1R neutralizing antibody (IGF1R nAb; AF-305-NA; R&D Systems) was reconstituted at 0.2 mg/ml in PBS and used at a final concentration of 2 mg/ml.
LY294002 is a specific inhibitor of PI3K with an IC50 of 1.40 mM (Vlahos et al., 1994) . Previously LY294002 has been used at concentrations of 500 mM to induce apoptosis in blastocysts and although 250 mM did not increase apoptosis in blastocysts (Riley et al., 2006) , this concentration was shown to decrease blastocyst hatching (Riley et al., 2005) . In the present study we chose to use a 5 mM LY294002, a concentration much closer to the IC50 for the drug.
Ishikawa cell culture
The Ishikawa cell line was a gift from Professor Chris Murphy, University of Sydney. Cells were thawed and plated on 10 mm glass coverslips (Menzel Glaser; Braunschweig, Germany) in 24-well plates (Corning, NY, USA) for co-culture experiments or directly on to 6 well pates (Corning, NY, USA) for western blot analysis with Dulbecco's modified Eagle's medium (DMEM; GIBCO, Grand Island, NY, USA) containing 10% (v/v) fetal bovine serum (FBS; Bovogen Biologicals Pty Ltd, Essendon, VIC, Australia) and 5000 I.U. of penicillin and 5000 mg of streptomycin per ml (Invitrogen, Camarillo, CA, USA).
Co-culture of mouse blastocysts with Ishikawa cells in the presence and absence of IGF1 Attachment experiment 1 (Fig. 1 ) was performed with co-culture of Ishikawa cells and blastocysts in the presence and absence of IGF1. Ishikawa cells that were near confluence were cultured in either serum medium (containing 10% FBS) or in serum starved (SS) medium (0.01% FBS) for 2 h prior to receiving Figure 1 Timeline of experiments used to study attachment of mouse blastocysts to human Ishikawa cells in vitro. BL: blastocyst. blastocysts. After 2 h, SS Ishikawa cells were then cultured in the presence or absence of 10 ng/ml IGF1. Blastocysts were isolated from six mice in each experiment. Between 4 and 12 Day 5 blastocysts were transferred per well on to the Ishikawa cells in each of the treatment groups. Blastocysts were randomly allocated to treatment groups and treatment groups were performed in duplicate. Initially, co-cultures were incubated undisturbed for 24 h and checked for attachment. However as no blastocysts had adhered at 24 h (up to Day 6), co-cultures were incubated undisturbed for 48 h (up to Day 7). Blastocyst attachment to Ishikawa cells was determined at 48 h by blowing media with a glass mouth pipette at the blastocysts whilst examining their position under a dissecting microscope (Wild M3 microscope; Leica Microsystems, Wetlar, Germany). Embryos that did not float away were considered to have attached (Singh et al., 2010) . Co-culture experiments were performed in duplicate and repeated three separate times. Data were pooled from the three separate experiments and counted as the proportion of blastocysts that had attached to the Ishikawa cells out of the total number of blastocysts added to the Ishikawa cells. Between 14 and 19 mice were used for each experimental group.
Pretreatment of blastocysts before co-culture with Ishikawa cells
Attachment experiment 2 (Fig. 1 ) was performed by pre-treating blastocysts before their co-culture with Ishikawa cells. Blastocysts were isolated from between 5 and 10 mice in each experiment. Day 5 blastocysts were cultured in the presence of serum, with or without 2 mg/ml IGF1R nAb or in SS medium in the presence or absence of 10, 100 or 1000 ng/ml IGF1 or with 10 ng/ml IGF1 in the presence of 2 mg/ml IGF1R nAb or 5 mM LY294002 (PI3 kinase inhibitor; Selleck, Houston, TX, USA) for 24 h. Blastocysts (now day 6 blastocysts) were then washed and cultured on Ishikawa cells for 24 h in SS medium and assessed for attachment as above. Experiments were repeated three to nine times and the data pooled to calculate the proportion of attached embryos for each treatment.
Immunofluorescence
Co-cultures, from attachment experiment 1 were examined for total focal adhesion kinase (FAK) protein expression. Blastocysts were isolated from between three and five mice in each experiment. Day 5 blastocysts were cultured in the absence of Ishikawa cells at low embryo density in SS medium in the presence or absence of 10 ng/ml IGF1 or 5 mM LY294002 and were examined for fibronectin expression at 24, 48 or 72 h. Co-cultures or separately cultured blastocysts were fixed in 4% paraformaldehyde (PFA) for 15 min, washed in PBS + 1 mg/ml Polyvinyl alcohol (PBS + PVA) and then permeabilised with PBS + PVA + 0.3% Triton X 100 for 30 min and then washed with PBS + PVA. Blocking was carried out in PBS + PVA + 0.1% Tween-20 + 0.7% BSA (PPTB) for 30 min. Primary and secondary antibodies were diluted in PPTB. Samples were incubated with primary antibodies [rabbit anti-integrin b3; Santa Cruz Biotechnology; #sc-14009, rabbit anti-FAK; Sigma; #F-2918 or rabbit anti-fibronectin (unattached blastocysts); Novus Biologicals, Littleton, CO, USA; #NBP1-91258, or rabbit anti-fibronectin antibody (for blastocysts attached to coverslips); Calbiochem, EMD Chemicals, Gibbstown, NJ, USA] overnight at 48C and then washed in PPTB before incubation with the secondary antibody (anti-rabbit Alexa 488; Life Technologies, Carlsbad, CA, USA) for 2 h at room temperature. Samples were then washed three times in PPTB, with the final wash lasting 10 min and then mounted in 5 ml Vectashield containing 1.5 mg/ml 4 ′ ,6 ′ -diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA, USA). Isotype controls were performed, in which cells were incubated with purified rabbit IgG (Sigma) in place of the primary antibody. Fluorescence was visualized using the LSM 510 Meta confocal microscope (Carl Zeiss, Germany) using a 405 nm laser and Argon laser (458, 477, 488 and 514 nm lines) at 40× objective. A Z-stack was taken through the co-cultures or the blastocysts, at 2.5 mm intervals. This provides us with sections throughout the whole blastocyst so that we can visualize the inner cell mass (ICM) in relation to the rest of the embryo. Images were analysed using LSM Image Browser software (Carl Zeiss) and the localization of proteins is described in relation to the ICM. An unbiased third party performed a blinded analysis of the immunofluorescence images.
Western blot analysis
All western blot data on Ishikawa cells are from Ishikawa cells cultured in the absence of blastocysts. Near confluent Ishikawa cells were allocated to serum medium or SS medium in the presence or absence of 10 ng/ml IGF1 for 48 h. Similarly all western blots on blastocysts were performed in the absence of Ishikawa cells. Blastocysts were isolated from at least eight mice in each experiment. Day 5 blastocysts were allocated randomly to serum medium or SS medium in the presence or absence of 10 ng/ml IGF1 and cultured for 48 h on non-adherent culture dishes (Corning). After 48 h, cells or blastocysts were washed in cold PBS and lysed with lysis buffer (Cell Signalling, Beverly, MA, USA) + 1 mM PMSF (Sigma). Collections were repeated until there were 120 embryos to run per lane, per experiment. Protein assays were carried out on Ishikawa cells according to the manufacturer's instructions (DC protein assay kit, Bio-Rad). Protein samples were diluted with 6× Laemmli buffer (35 mM Tris-HCl, pH 6.8, 10.28% (w/v) sodium dodecyl sulphate (SDS), 36% (v/v) glycerol, 0.05% (w/v) bromophenol blue; Sigma) and heated for 5 min at 1008C. Proteins were electrophoresed on an 8% SDS -polyacrylamide gel, transferred to a nitrocellulose transfer membrane (Hy-BLOT, Australia) and then incubated in blocking buffer (Odyssey; Li-cor Biosciences, Lincoln, NE, USA) overnight at 48C with gentle shaking. Membranes were probed with primary antibodies (rabbit anti-E-cadherin; Novus Biologicals; #NB110-56937, rabbit anti-pFAK; Invitrogen; #44-624G, or rabbit anti-integrin b3; Santa Cruz Biotechnology; #sc-14009 or mouse anti-a-tubulin; Sigma; #T9026) overnight at 48C in blocking buffer + 0.1% Tween-20. Membranes were washed in Trisbuffered saline + Tween 20 (TBST; 10 mM Tris -HCl, pH 7.6, 150 mM NaCl and 0.1% Tween 20) and subsequently incubated for 2 h with either 1:4000 Donkey anti-Rabbit IRDye 800CW (Odyssey) or 1:4000 Donkey anti-Mouse IRDye 680LT (Odyssey). Proteins were visualized using the Odyssey infrared imager and Odyssey application software, version 3 (Odyssey). Densitometry was performed using Image-J software (National Institutes of Health, Bethesda, MD, USA) or Odyssey program.
Flow cytometry
Surface expression of integrin avb3, b3 and b1 on Ishikawa cells, cultured in the absence of blastocysts, was analysed by flow cytometry after 48 h culture in serum medium or SS medium in the presence or absence of 10 ng/ml IGF1. Cells were removed from the culture plate with 0.5% trypsin (Life Technologies). Cells were resuspended in 600 ml of PBS + 0.3% BSA and incubated with primary antibodies pre-conjugated (1:200 anti-human integrin avb3; eBioscience; San Diego, CA, USA; #11-0519-41, anti-human integrin b3; eBioscience; #11-0619-41 or anti-human integrin b1; eBioscience; #11-0299-41) or isotype control antibodies (Armenian hamster IgG/Rat IgG 2a/2b; Biolegend; San Diego, CA, USA; #78023) for 30 min on ice. Samples were then washed and resuspended in 200 ml PBS + 0.1% (v/v) propidium iodide (Sigma). Analyses were performed using the FACS Calibur (Becton Dickinson, San Jose, CA, USA) and Cell Quest (Becton Dickinson) and Flow Jo (Treestar, San Carlos, CA, USA) software packages. A minimum of 10 000 cells were analysed per sample.
Blastocyst outgrowth
Blastocysts were isolated from at least five mice in each experiment. Day 5 blastocysts were cultured on 24-well plates (Corning) that were either uncoated, or coated with fibronectin. To coat wells, fibronectin was made to IGF1 Increases mouse blastocyst attachment in vitro a concentration of 25 mg/ml in PBS, and enough solution was added to cover each well and left at 4 8C overnight. Blastocysts were allowed to outgrow, undisturbed for 72 h in serum medium or in SS medium in the presence or absence of 10 ng/ml IGF1 with or without 5 mM LY294002 (Selleck). At 72 h blastocyst outgrowths were micrographed on the Axiovert 35 microscope (Carl Zeiss) using a Axiocam ICc5 camera (Carl Zeiss) and Zen image software (Carl Zeiss). For those blastocysts that were attached to the well, the area of outgrowth (arbitrary units), along with blastocyst area was measured using Image-J software (National Institute of Health) by tracing around the outgrown cells using the freehand area selection tool and then the wand tool to obtain an area value in arbitrary units. Experiments were repeated three to eight times and the data pooled to calculate the average area of outgrowth.
Statistical analysis
Embryos collected from multiple mice were randomly allocated between treatments for all experiments. Chi-squared analysis of the overall proportion of blastocysts attached to Ishikawa cell co-cultures was performed on pooled proportion data from three separate experiments (Microsoft Office Excel, Berkshire, UK). Western blot analysis was performed three times. The optical density of protein bands was normalized to a-tubulin and expressed relative to the control, followed by statistical analysis using unpaired t-tests (Microsoft Office Excel). Flow cytometry analysis was performed three times, followed by statistical analysis of the average fluorescence intensity, using unpaired t-tests (Microsoft Office Excel). Embryo outgrowth experiments were performed at least three times, followed by statistical analysis using Kruskal -Wallis test followed by Dunn multiple comparison test for non-parametric data (GraphPad Prism version 6.00 for Windows, GraphPad Software, La Jolla, CA, USA, www.graphpad.com). A P , 0.05 was considered statistically significant.
Results

Effect of IGF1 on attachment of mouse blastocysts to Ishikawa cells in vitro
Blastocyst attachment was assessed in the presence orabsence of 10 ng/ml IGF1 (attachment experiment 1) after 24 and 48 h, before fixation with PFA (Singh et al., 2010) . At 24 h no blastocysts had attached to the Ishikawa cells in any of the treatment groups (data not shown). Therefore attachment was assessed at 48 h. The proportion of blastocysts that attached to Ishikawa cells under SS conditions (27 attached/50) was reduced compared with attachment in the presence of serum (39 attached/47; Fig. 2 ). The presence of IGF1 increased the proportion of blastocyst attachment (IGF1: 39 attached/46) compared with attachment in SS conditions (Fig. 2) , to the level seen in the presence of serum.
Effect of IGF1 on E-cadherin and integrin b3 protein levels and integrin avb3, b3 and b1 surface expression in Ishikawa cells
As IGF1 increased attachment of blastocysts to Ishikawa cells, the effect of IGF1 on several adhesion proteins was investigated in Ishikawa cells by western blot. There was no difference in E-cadherin expression in Ishikawa cells between the serum, SS or SS plus IGF1 treatment groups (Fig. 3A) . Furthermore, IGF1 had no effect on integrin b3 expression in Ishikawa cells; however, expression of integrin b3 was increased in the presence of serum (Fig. 3B) .
Although IGF1 had no effect on total expression of integrin b3 in Ishikawa cells, it is the integrin expression on the apical surface that is required for interaction with ECM proteins. Therefore, surface expression of avb3, b3 and b1 integrins was investigated in Ishikawa cells using flow cytometry. Integrins avb3, b3 and b1 were all expressed on the cell surface in Ishikawa cells, as indicated by the greater fluorescence seen with the presence of each antibody compared with the isotype control (Fig. 3C) . However, there was no difference in surface expression of integrins avb3, b3 or b1 between any of the treatment groups (Fig. 3C) .
Effect of IGF1 on phosphorylation of FAK and total FAK expression levels in Ishikawa cells and mouse blastocysts FAK signalling is linked to integrin activation (Kornberg et al., 1992) . Therefore, activation of FAK signalling pathways, indicated by phosphorylation of FAK (p-FAK) was investigated by western blot analysis in Ishikawa cells and blastocysts. Phosphorylation of FAK was increased in Ishikawa cells after 48 h treatment with 10 ng/ml IGF1 (Fig. 4A) . Immunofluorescence was used to show that total FAK expression in Ishikawa cells was increased on the apical surface in co-cultures after treatment with IGF1 for 48 h. Similarly, total FAK expression was increased in blastocysts that were attached to Ishikawa cells in co-cultures in the presence of IGF1 in comparison to co-cultures in the absence of IGF1 (Fig. 4B) . The rabbit IgG isotype control had no detectable immunofluorescence staining in either the blastocyst or Ishikawa cells (data not shown). Western blots were performed on unattached blastocysts and showed no effect on phosphorylation of FAK or total FAK levels in blastocysts after IGF1 treatment for 48 h (Fig. 4C and D) . 
Fibronectin localization in early and late stage blastocysts
Fibronectin is an important ECM protein that is secreted by blastocysts but not by Ishikawa cells (Kaneko et al., 2013) . The expression and localization of fibronectin in blastocysts was investigated by immunofluorescence over 72 h of culture, in the presence or absence of IGF1. Here we describe the change in fibronectin expression over time as well as an IGF-induced increase in fibronectin expression over time. Day 5 blastocysts were cultured in SS medium in the presence or absence of 10 ng/ ml IGF1 and collected at 24, 48 and 72 h and then immunostained for fibronectin. At 24 h (now day 6 blastocyst), fibronectin was located in the cytoplasm, nucleus, cell -cell junctions and on the basal and apical surface of the cells in the trophectoderm (Fig. 5A and B) . The ICM also expressed fibronectin but this was restricted to the cells facing the blastocoel. IGF1 treatment had no effect on fibronectin localization or staining intensity at 24 h. IGF1 treatment increased fibronectin staining intensity at 48 h compared with the SS control (Fig. 5C versus D) . At 48 h (Day 7 blastocyst), fibronectin was located in the cytoplasm, nucleus, cell -cell junctions and on the basal and apical surface of the trophectoderm (Fig. 5C and D) and this staining was polarized to one side of the blastocyst. At 48 h the majority of ICM cells had lost fibronectin expression. The localization at 48 h was comparable between the SS control and IGF1 group. At 72 h (Day 8 blastocyst), there was a distinct polarization of fibronectin in the trophectoderm on one side of the blastocyst and the localization was cytoplasmic and punctate. There was no staining in the ICM (Fig. 5E and F) . At 72 h in the IGF1 treated group, fibronectin staining was of a much higher intensity, compared with the SS group (Fig. 5E versus F) . Additionally, IGF1 treatment resulted in a distinct apical localization of fibronectin. The polarized fibronectin staining seen at 48 and 72 h in blastocysts partially covers the trophoblast cells at the embryonic pole and extends from the embryonic pole to the abembryonic pole on one side of the blastocyst. This is the side that attached to Ishikawa cells in vitro.
The addition of the PI3 kinase inhibitor, 5 mM LY294002, to IGF1 treated blastocysts affected the overall polarization of fibronectin and compared with the intense apical staining seen in IGF1 treated blastocysts the localization of fibronectin in LY294002 treated blastocysts in the presence of IGF1, was more cytoplasmic and strong staining in the cell-cell junctions was present (Fig. 5F versus G) .
To ensure the polarized fibronectin staining was functionally related to attachment, blastocysts treated with IGF1 that had adhered to glass coverslips (72 h) were imaged for fibronectin staining. The attached surface 
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of the blastocyst expressed fibronectin. The surface of the blastocyst facing away from the coverslip did not express fibronectin (Fig. 5H) .
Effect of IGF1 on blastocyst outgrowth
Fibronectin is known to increase blastocyst outgrowth in serum free medium to the level seen in the presence of serum (Armant et al., 1986) . Therefore blastocyst outgrowth was measured after 72 h (now day 8 blastocysts) of culture on either uncoated wells or wells coated with fibronectin, in serum medium or SS medium in the presence or absence of 10 ng/ml IGF1 or 5 mM LY294002. Culture of blastocysts in serum medium significantly increased the average area of blastocyst outgrowth compared with SS blastocysts and blastocysts cultured in the presence of IGF1 (Fig. 6H ) and this was seen as an increase in trophectoderm spreading across the culture dish (Fig. 6A-C) . Under SS conditions blastocyst outgrowth was increased by the presence of IGF1 when blastocysts were cultured on uncoated wells (Fig. 6B, C and H) . Blastocyst outgrowth in SS media was increased when blastocysts were cultured on fibronectin coated wells (Fig. 6B, D and H) . The outgrowth of blastocysts in the presence of IGF1 was not improved by fibronectin ( Fig. 6C versus E and H) . Outgrowth in the presence of IGF1 and LY294002 on either uncoated or fibronectin coated wells was decreased compared with outgrowth in IGF1 alone on either uncoated or fibronectin coated wells, respectively (Fig. 6F -H) .
Effect of pretreatment with IGF1, an IGF1R nAb or LY294002 on attachment of mouse blastocysts to Ishikawa cells
In attachment experiment 2, Day 5 blastocysts were cultured in serum medium containing 2 mg/ml IGF1R nAb or in SS medium in the presence or absence of 10, 100 or 1000 ng/ml IGF1 or with 10 ng/ml IGF1 in the presence of 2 mg/ml IGF1R nAb or 5 mM LY294002 for 24 h. At the end of this pretreatment period the health of blastocysts cultured in LY294002 was assessed and blastocysts (Day 6 blastocysts) were of healthy appearance (Fig. 7A-D) . Blastocysts were washed in SS medium and then cultured on Ishikawa cells for 24 h, under SS conditions and assessed for attachment (on Day 7). All blastocysts in all treatment groups remained of normal appearance after the co-culture period (data not shown).
Pretreatment of blastocysts with serum for 24 h did not improve attachment form the serum staved group (Fig. 7E) . Pretreatment of blastocysts with an IGF1R nAb in the presence of serum had no effect on blastocyst attachment compared with pretreatment with serum (Fig. 7E) . Pretreatment with 10 ng/ml IGF1 for 24 h increased blastocyst attachment to Ishikawa cells compared with pretreatment in SS medium or medium containing serum (Fig. 7E) . The positive effect of IGF1 pretreatment on attachment was reduced by the IGF1R nAb, to the level seen in SS conditions (Fig. 7E) . Additionally, pretreatment of blastocysts with the PI3K inhibitor LY294002 in the presence or absence of IGF1 reduced blastocyst attachment to Ishikawa cells compared with SS or IGF1 pretreatment conditions, respectively (Fig. 7E) . Pretreatment of blastocysts with higher concentrations of IGF1 (100 and 1000 ng/ml) did not increase blastocyst attachment compared with the SS control.
Discussion
A number of growth factors and their receptors are expressed by both the preimplantation embryo and the reproductive tract and these influence preimplantation embryo development and implantation (Hardy and Spanos, 2002; Armant, 2005) . In particular, growth factors such as IGF1, which are produced by the embryo and at the implantation site, are thought to play a role in the co-ordination of blastocyst implantation ability with uterine receptivity (Wang et al., 2000; Armant, 2005) . In the present study we used an in vitro model for embryo attachment to investigate the effect of IGF1 on mouse blastocyst adhesion competency. Co-culture of blastocysts with Ishikawa cells for 48 h, under SS conditions, decreased blastocyst attachment compared with attachment in the presence of serum, which is well known to contain a large number of growth factors. Addition of IGF1 to the co-cultures, in the absence of serum, increased attachment to a level similar to that observed in the presence of serum, suggesting that IGF1 alone can support attachment of blastocysts to Ishikawa cells in vitro. Furthermore, pretreatment of Day 5 blastocysts with IGF1 for 24 h was sufficient to improve blastocyst attachment to Ishikawa cells compared with pretreatment in SS medium. This suggests that the in vitro cultured embryo can be manipulated by growth factors, normally found in vivo, to increase the blastocyst's adhesive ability.
The effects of IGF1 on blastocyst attachment were mediated by the IGF1R as an IGF1R nAb negated the positive effects of IGF1 pretreatment on blastocyst attachment. In the blastocyst IGF1 is known to phosphorylate Akt (Green and Day, 2013) , a signalling molecule downstream of the PI3K pathway. In the present study the PI3K inhibitor LY294002 prevented the increase in attachment mediated by IGF1. LY294002 also decreased attachment in SS blastocysts, suggesting that even in SS conditions there may be autocrine growth factor stimulation or constitutive activation of the PI3K pathway to influence attachment. In the present study, pretreatment with serum did not improve blastocyst attachment, in fact attachment in these conditions was reduced compared with attachment after IGF1 pretreatment. High levels of insulin and other growth factors that are present in serum may have negative effects on blastocyst attachment, although serum appears to positively influence Ishikawa cells to mediate attachment.
High concentrations of IGF1 are known to be detrimental to the blastocyst by decreasing blastocyst hatching (Green and Day, 2013) and increasing apoptosis (Chi et al., 2000) . High concentrations of Figure 5 IGF1 increases apical fibronectin in late stage blastocysts. Representative confocal images of blastocysts stained for fibronectin (Green) and DAPI (Blue). Day 5 blastocysts were cultured in SS medium for 24 (A and B), 48 (C and D) or 72 h (E-H) in the absence (A, C and E) or presence (B, D and F) of 10 ng/ml IGF1 or in the presence of a PI3 Kinase inhibitor (5 mM LY294002 + 10 ng/ml IGF1) (G) or in the presence of 10 ng/ml IGF1, attached to a coverslip (H). Scale bars represent 20 mm. Red line indicates location of coverslip. Arrow indicates location of the inner cell mass (ICM). The following total number of blastocysts were analysed, from at least 3 experimental repeats in each treatment; 24 in the SS group (24 h), 21 in SS plus IGF1 (24 h), 26 in SS (48 h), 30 in SS plus IGF1 (48 h), 40 in SS (72 h), 59 in SS plus IGF1 (72 h), 13 in SS plus IGF1 + LY294002 (48 h) and 15 blastocysts were analysed that were attached to a coverslip (72 h).
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IGF1 have also been shown to decrease normal blastocyst implantation sites and increase resorption compared with the level seen in blastocysts exposed to physiological IGF1 concentrations (Pinto et al., 2002) . In the present study, pretreatment of blastocysts with high concentrations of IGF1 did not improve blastocyst development unlike 10 ng/ml IGF1. These effects could be due to the IGF1R down-regulation over time, in response to high IGF1 concentrations (Pinto et al., 2002) . Taken together these data highlight our previous finding that the total concentration of IGF1 must be tightly controlled in order to provide for optimal development.
Both pretreatment of blastocysts with IGF1 as well as co-culture of blastocysts and Ishikawa cells with IGF1 was sufficient to increase attachment. IGF1, therefore, acts on the blastocyst to mediate attachment and may also increase attachment via actions on the Ishikawa cells. Thus the molecular mechanisms by which IGF1 improved attachment were investigated in Ishikawa cells and blastocysts. Integrins are present in the apical membrane of endometrial epithelial cells at the time of implantation in human, mouse and rat (Sutherland et al., 1993; Aplin et al., 1996; Schultz et al., 1997; Kaneko et al., 2011a,b) . Treatment of Ishikawa cells with IGF1 for 48 h had no effect on total expression of either E-cadherin, or integrin b3 expression levels. Integrins avb3, b3 and b1 were expressed at the cell surface in Ishikawa cells; however, IGF1 treatment had no effect on this surface expression. Although there was no change in integrin localization or expression in Ishikawa cells by IGF1 treatment, total expression of integrin b3 expression was increased by serum.
Fibronectin is produced by the embryo (Wartiovaara et al., 1979; Yohkaichiya et al., 1988; Thorsteinsdottir, 1992; Kaneko et al., 2013) , and is one of the important bridging ligands, providing the RGD site for the recognition by integrins expressed on the apical surface of both the endometrium and the embryo (Kaneko et al., 2013) . IGF1 increased apical fibronectin expression in blastocysts after 48 and 72 h of treatment, correlating with the time of blastocyst attachment and outgrowth in vitro. This increase in fibronectin at the apical surface may be responsible for the increase in attachment of blastocysts to Ishikawa cells as the side of the blastocyst that expressed fibronectin was the side that attached in vitro. The overall polarity of fibronectin appeared to be developmentally regulated, as fibronectin relocalised from trophectoderm cell-cell contacts (at 24 h culture) to the apical membrane (after 48 h culture) at the time of attachment in vitro. Together these data suggests that fibronectin produced by the mouse blastocyst is an important ECM protein for attachment, acting as a possible bridging ligand for the integrins expressed at the maternal -embryo interface and that fibronectin polarization may control the orientation of attachment to an underlying cell layer.
Furthermore the acquisition of fibronectin on blastocysts from Day 7 onwards may regulate adhesion competency of the blastocyst. This was demonstrated by the inability of Day 5 blastocysts to attach to Ishikawa cells after 24 h (Day 6), whereas pretreatment of Day 6 blastocysts with IGF1 before placing them on Ishikawa cells enabled attachment after only 24 h (Day 7). This IGF1 induced increase in blastocyst attachment correlated with the increase in apical fibronectin on blastocysts by IGF1 and suggests that attachment is dependent on the adhesive competency of the blastocyst, which is developmentally regulated and can be increased by IGF1.
Fibronectin is also known to increase blastocyst outgrowth and therefore, as IGF1 increases fibronectin expression, we hypothesized that IGF1 would also increase blastocyst outgrowth. We observed an increase in blastocyst outgrowth on wells coated with fibronectin, in the absence of IGF1, as well as an increase in blastocyst outgrowth in the (B and D) or presence (C, E, F and G) of 10 ng/ml IGF1 and/or in the presence of a PI3 Kinase inhibitor (5 mM LY294002 + 10 ng/ml IGF1) (F and G) in SS conditions (SS). Scale bars represent 40 mm. (H) Average outgrowth area of blastocysts + SEM cultured in serum medium (black bar) or SS medium (white bars) in the presence or absence of 10 ng/ml IGF1 and/or in the presence of a PI3 Kinase inhibitor (5 mM LY294002 + 10 ng/ml IGF1), pooled from at least three experiments. N values are given in parentheses and represent the total number of blastocysts analysed across three to eight experiments). Kruskal-Wallis test followed by Dunn's multiple comparison test for non-parametric data was used to compare preselected treatment groups. Lines between bars show compared groups with significance. * indicates P , 0.05, ** indicates P , 0.01 and *** indicates P , 0.001. AU: arbitrary units.
presence of IGF1 or serum. To our knowledge the effect of IGF1 on blastocyst outgrowth has not been previously studied; however, IGF1 has been shown to increase lamellipodia formation in trophoblast cells (Kabir-Salmani et al., 2002) . Blastocyst outgrowth was also increased in the presence of serum compared with SS or IGF1 treated blastocysts suggesting that other factors found in serum influence outgrowth.
Blastocyst attachment and outgrowth on fibronectin, is most likely mediated by fibronectin-integrin interactions. It has previously been appearance after 24 h pretreatment in SS medium in the presence or absence of 10 ng/ml IGF1 and/or in the presence of LY294002. (E) Attachment of blastocysts to Ishikawa cells under SS conditions after pretreatment in the presence of serum (black bars), with or without 2 mg/ml IGF1R neutralizing antibody (IGF1R nAb) or in SS medium (white bars) in the presence or absence of 10, 100 or 1000 ng/ml IGF1 or with 10 ng/ml IGF1 in the presence of 2 mg/ml IGF1R nAb or 5 mM LY294002 (PI3 kinase inhibitor) for 24 h. Results are displayed as the percentage of blastocysts attached to the Ishikawa cells, pooled from at least three experiments. N values in parentheses represent the total number of blastocysts added to the Ishikawa cells, pooled from three to nine experiments. Chi-square analysis was used to compare pre-selected treatment groups. Lines between bars show compared groups with significance. * indicates P , 0.05, ** indicates P , 0.01 and *** indicates P , 0.001.
shown that attachment of rat blastocysts to Ishikawa cells in vitro is reduced by pre-incubation of blastocysts and or Ishikawa cells with the RGD-blocking peptide (Kaneko et al., 2013) . In outgrowth studies, the FN-120 fragment in fibronectin, which contains the RGD sequence, promotes blastocyst outgrowth, whereas the FN-50 fragment, which is lacking the RGD sequence, impairs blastocyst outgrowth (Yelian et al., 1995) . Furthermore, function blocking antibodies to integrin b1 and b3 also reduced fibronectin binding on trophoblast cells and inhibited blastocyst outgrowth in mice Yelian et al., 1995) . In human extravillous trophoblast cells IGF1 treatment increases fibronectin binding and this is also blocked by an RGD-blocking peptide (Kabir-Salmani et al., 2002) .
Integrin signalling is a complex process that involves both alterations in integrin affinity for ECM through pathways downstream of growth factor signalling (inside-out signalling), and signalling downstream of integrin-ECM interactions (outside-in signalling) (Sastry and Horwitz, 1993) . FAK is a major component of the outside-in integrin signal transduction pathway to regulate a variety of cellular events (reviewed in (Schaller, 2001) ). FAK is not only activated by integrin-ECM ligation, but also is phosphorylated by hormones and growth factors, including insulin and IGF-1 (Baron et al., 1998, Casamassima and Rozengurt, 1998) . In the present study treatment of Ishikawa cells with IGF1 for 48 h increased phosphorylation of FAK at Tyr397. Total FAK was also increased by IGF1 and its expression was apical. In the endometrium FAK is up-regulated in the early proliferative to mid secretory stage, suggesting a role of FAK in implantation (Orazizadeh et al., 2009) . As FAK can regulate integrin activation to promote integrin binding (Michael et al., 2009) , the up-regulation of FAK phosphorylation at Tyr397 in Ishikawa cells by IGF1 may play a role in integrin recognition of ECM proteins secreted by the blastocyst, and can explain the increase in attachment seen on Ishikawa cells, although IGF1 did not increase surface expression or total expression of integrins.
IGF1 treatment for 2 h has been shown to phosphorylate FAK in trophoblast cells obtained from human 6-10 week placental tissue (Kabir-Salmani et al., 2002) . In the present study total FAK staining after IGF1 treatment in blastocysts attached to Ishikawa cells appeared to be stronger, although this was not quantified. However in unattached blastocysts no change in phosphorylated or total FAK after IGF1 treatment was observed, suggesting that FAK phosphorylation is dependent on attachment status (Baron et al., 1998) .
Akt is another signalling mediator that is necessary for integrin activation and has been shown to regulate fibronectin assembly through activation of integrin a5b1 (Somanath et al., 2007) . Akt is known to be activated by IGF1 in mouse blastocysts (Green and Day, 2013) . In the present study, inhibition of PI3K prevented the polarized distribution of fibronectin in blastocysts treated with IGF1. PI3K inhibition also decreased blastocyst outgrowth in the presence of IGF1 as well as attachment of blastocysts to Ishikawa cells, possibly due to the decrease in apical fibronectin. However, the overall intensity of fibronectin staining remained high in the presence of the PI3K inhibitor, suggesting that fibronectin synthesis in the blastocyst is via a signalling pathway other than PI3K.
In summary, the present study demonstrated that IGF1 improved the adhesion competency of the mouse blastocyst. IGF1 up-regulated fibronectin expression on the apical surface of the trophoblasts, via activation of the PI3K/Akt pathway and we propose that this increases blastocyst adhesion competency (Fig. 8) . IGF1 also activated FAK expression and signalling in Ishikawa cells, potentially regulating integrin activation in order to prime the cells for interaction with the fibronectin on the blastocyst (Fig. 8) . These findings provide evidence for the important role that IGF1 plays in vivo, in the co-ordination of blastocyst adhesion competency and uterine receptivity. This study used a heterologous yet well documented model to study adhesion of mouse blastocysts to the human Ishikawa cell line in response to IGF1. This system would be useful to study IGF1 adhesion regulation of human blastocysts or a spheroidal human trophoblast cell line such as JAr cells. At the time of implantation in the human there is a sufficient amount of IGF1 present in the uterine and luminal secretions (Lighten et al., 1998) ; however, this maternal IGF1 is absent during the in vitro culture of embryos. As failure of the embryo to implant successfully is a major cause of IVF failure (Miller et al., 2012) , our results, along with others (Lighten et al., 1998; Green and Day, 2013) indicate that pretreatment of human blastocysts with IGF1 before their introduction back into the uterus may be a possible avenue to improve implantation rates in assisted reproduction.
